Fagron Recalls Phytobase Cream Lots Due to Mold Contamination
Fagron is recalling six lots of Phytobase Cream, a prescription compounding vehicle, due to the presence of mold.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves microbial contamination (mold) in a non-sterile product. Per the rubric, high-risk pathogens or risk-of-harm products where injury has not yet been reported are classified as High (Score 3). No illnesses or injuries are reported in the source text.
Plain-English summary
Fagron, Inc. is recalling six lots of Phytobase Cream, 500 g, Article number 802156. This product is a prescription-only natural self-emulsifying oil-in-water vehicle used for prescription compounding of oil-soluble ingredients. It contains phytosomes (plant oil bodies) and is manufactured by Fagron, Inc. in St. Paul, Minnesota.
The recall is being conducted due to the presence of mold in the non-sterile product. The affected lots are identified by the following lot numbers and expiration dates: Lot # 13J30-U17-015413 (Exp 10/15), Lot # 13J30-U16-015425 (Exp 10/15), and Lot # 13I06-U05-014199 (Exp 10/15). The source text indicates a total of six lots are involved, though only three specific lot numbers are listed in the provided structured data.
The product was distributed nationwide and in Australia. A total of 430 jars are affected. Consumers and healthcare providers should stop using the affected product and contact their pharmacist or Fagron, Inc. for further instructions.
The recalled product
- Product
- Fagron, Phytobase Cream, 500 g, Article number: 802156. RX only, For prescription compounding Natural self-emulsifying oil-in water vehicle for oil-solvents ingredients. Contains Phytosomes (Plant Oil Bodies), Manufactured by Fagron, Inc. 2400 Pilot Knob Rd, St Paul, MN 55120…
- Manufacturer
- Fagron, Inc
- Category
- Drug — Compounding Ingredient
- Affected units
- 430
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 13J30-U17-015413
- Exp 10/15 Lot # 13J30-U16-015425
- Exp 10/15 Lot # 13I06-U05-014199
- Exp 10/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Fagron, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recalled Due to Incorrect Label Strength
FDA (Drugs) · 2023-12-27
- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- HighNystatin bulk powder recall due to incorrect assay strength label
FDA (Drugs) · 2023-12-27
- ModerateFDA Recalls Subpotent Nandrolone Decanoate Compounding Ingredient
FDA (Drugs) · 2022-05-18
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereFagron Recalls SyrSpend SF Suspending Base Due to Microbial Contamination
FDA (Drugs) · 2018-03-07
- ModerateFagron Recalls Estrone Compounding Powder Due to Quality Assurance Deviations
FDA (Drugs) · 2017-05-31
- ModerateFagron Recalls Estriol Compounding Powder Due to Quality Assurance Deviations
FDA (Drugs) · 2017-05-31
- ModerateFagron Recalls SyrSpend SF Suspending Base Due to Yeast Contamination
FDA (Drugs) · 2016-02-17
- LowFougera Recalls Ketoconazole Cream Due to Out-of-Specification Degradants
FDA (Drugs) · 2014-02-05
- LowFougera Recalls Ketoconazole Cream 2% Due to Unknown Degradant
FDA (Drugs) · 2013-04-10